Abstract:Undesired gene expression can lead to severe diseases such as cancers. Oncogenic proteins or survival factors encoded by oncogenes can sustain cancer cell survival and proliferation. Considering that proteins are manufactured and transported by the endoplasmic reticulum (ER), the destroying of oncogenic proteins within the ER could cut-off the process of undesired gene expression. In this study, a new type of ER targeting strategy was developed based on the coordination interaction of the Ca(II) ion rich ER lumen with the carboxyl group of poly(aspartic acid) (PAsp). A comblike polymer PAsp-g-(PEG-ICG) was rationally designed and successfully prepared by grafting azido-modified polyethylene glycol (PEG) and the azido-modified photosensitizer indocyanine green (ICG) onto alkynyl-modified PAsp through the copper(I)catalyzed alkyne-azide cycloaddition (CuAAC). Here, ICG not only shows its importance as an imaging agent that reveals the distribution of PAsp-g-(PEG-ICG) micelles both at tissue and subcellular levels, but also acts as a protein destructive agent to generate reactive oxygen species (ROS) resulting in protein denaturation. Moreover, chemotherapeutic drugs, such as paclitaxel, can be easily encapsulated into PAsp-g-(PEG-ICG) (PTX@PAsp-g-(PEG-ICG)) in up to 28% drug loading capacity with excellent stability. The experimental results proved that the as-prepared PTX@PAsp-g-(PEG-ICG) micelles exhibited selective accumulation in the ER lumen of cancer cells. Thus, a 10-fold enhancement of ROS was obtained by incubating cancer cells with PAsp-g-(PEG-ICG) micelles at a PTX concentration of 1.0 mu g ml(-1) under laser irradiation (0.2 W cm(-2), 785 nm, 30 s) for 24 h, leading to disruption of proteins in the ER that caused ER stress-induced cancer cell apoptosis up to 76%. In a cytotoxicity test, U-87 MG glioma cells incubated with PTX@PAsp-g-(PEG-ICG) at the PTX concentration of 2.5 mu g ml(-1) were reduced to nearly 0% of cell viability upon 24 h laser irradiation (2 W cm(-2), 785 nm, 30 s), in comparison with free PTX that showed 60% cell viability under the same conditions, indicating that photodynamic therapy (PDT) remarkably enhanced chemotherapeutic effects. With the good combination of PDT and chemotherapy, the PTX@PAsp-g-(PEG-ICG) micelles offer unprecedented advantages by effectively targeting the ER and displayed a prolonged retention time in the tumors of U-87 MG bearing nude mice, providing great promise for manipulating biomaterial design to achieve the intended ER targeted delivery for non-invasive cancer therapy.

ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines

Combination of GNRs-PEI/cGAMP-laden Macrophages-Based Photothermal Induced in Situ Tumor Vaccines and Immune Checkpoint Blockade for Synergistic Anti-Tumor Immunotherapy.

Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death

Rationally Integrated Precise ER‐targeted And Oxygen‐compensated Photodynamic Immunostimulant for Immunogenicity‐boosted Tumor Therapy

Photodynamic Modulation of Endoplasmic Reticulum and Mitochondria Network Boosted Cancer Immunotherapy

A Cancer Vaccine-Mediated Postoperative Immunotherapy for Recurrent and Metastatic Tumors.

Tumor-penetrating Peptide Irgd Conjugation Effectively Potentiates Intratumor T Cell Infiltration.

Targeting Lysosome for Enhanced Cancer Photodynamic/Photothermal Therapy in a "One Stone Two Birds" Pattern

Synthesis of indocyanine green functionalized comblike poly(aspartic acid) derivatives for enhanced cancer cell ablation by targeting the endoplasmic reticulum

Multifunctional nanoparticles potentiate in-situ tumor vaccines via reversing insufficient Photothermal therapy by disrupting tumor vasculature

ROS-responsive and triple-synergistic mitochondria-targeted polymer micelles for efficient induction of ICD in tumor therapeutics

Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers

Smart Nanovesicle-Mediated Immunogenic Cell Death Through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.

Enhancing tumor immunotherapy via photodynamic therapy with a cascade reaction of reactive oxygen species and sustaining nutrient supply

Peptide-IR820 Conjugate: A Promising Strategy for Efficient Vascular Disruption and Hypoxia Induction in Melanoma

Antigen‐Capturing Dendritic‐Cell‐Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy‐Induced in‐situ Vaccination

A NIR‐Light‐Activated and Lysosomal‐Targeted Pt (II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

ER-Targeting Cyanine Dye as an NIR Photoinducer to Efficiently Trigger Photoimmunogenic Cancer Cell Death

Molecular Imaging-Guided Photothermal/photodynamic Therapy Against Tumor by Irgd-Modified Indocyanine Green Nanoparticles.

Polymer‐Reinforced Liposomes Amplify Immunogenic Cell Death‐Associated Antitumor Immunity for Photodynamic‐Immunotherapy

Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation